.
Human exposure to dietary genistein and daidzein occurs mainly through intake of soy food [17] . Concentrations of these agents in soy average 2 g/kg (dry wt.) but vary greatly [18] [19] [20] [21] .
Traditionally, gas chromatography-mass spectrometry (GC-MS) has been applied to determine soy isoflavones and their metabolites in human biological fluids, including urine [8, 22, 23] , plasma [24] , and feces [25, 26] .' Recently, the introduction of HPLC to measure these anaiytes in human urine [27, 28] has allowed the measurement of a varietyof phytoestrogens, including aglycones and conjugated analytes, in one run.
Compared with GC-MS, HPLC required fewer steps for sample preparation and analysis and demanded less technician time and less expensive instrumentation. In independent studies of soy intervention, HPLC [27] proved to be as accurate as GC-MS [8, 23] for measuring urinary isoflavone concentrations, as evidenced by similar results achieved in these trials.
Although isoflavone metabolites such as equol and its derivatives have been identified in cow's milk [29, 30] , to our knowledge the presence of dietary isoflavones in human milk has not been reported.
In support of future studies favoring noninvasive protocols and assessing the potential cancer protective role of a diet containing soya or isoflavones, we developed an HPLC procedure to determine, for the first time, concentrations of soy isofiavones in human miik. 
Materials and Methods

PARTICIPANTS
PROCEDURES
Extraction and acid hydrolysis of isoflavones from soybeans. Roasted soybeans were extracted as described previously [17] . In brief, 1 g of soybeans was homogenized and extracted with simultaneous hydrolysis by refluxing for I h in a mixture of 10 mL of conc. hydrochloric acid and 40 mL of 96% aqueous ethanol containing 20 Mg/L flavone (internal standard) and 0.25 g/L butylated hydroxytoluene.
Enzymatic hydrolysis and extraction of isoflavones from human milk.
We mixed 2-4 mL of human milk equilibrated to room temperature with 25 ML of flavone solution (120 MgfL in 96% ethanol), 50 ML of 13-glucuronidase reagent (200 kU/L), and 50
ML of arylsulfatase reagent (5 kU/L) and then stirred this for 1 h at 37 #{176}C. This sample was extracted threetimes with 2 mL of ethyl acetate (ACS-certified) and the organic phases were combined aftercentrifugation; the combined phases were then dried under nitrogen.
The dry extract was redissolved in 150 ML of methanol by vortex-mixing, after which 50 ML of 0.2 mol/L acetate buffer (pH 4) was added. After centrifugation, 150 ML of clear sample was put in an insert of an amber vial for automated HPLC injections of 20-ML samples.
In a parallel experiment, we mixed 25 ML of flavone (120 Mg/L in 96% ethanol) with 130 ML of methanol and 45 ML of 0.2 mol/L acetate buffer (pH 4) in the same batch for calculating the recovery of the internal standard.
Extraction and enzymatic hydrolysis of urinary isoflavones. Urine was extracted as described previously [27] . In brief, 20 mL of clear urine was mixed with 5.0 mL of 0.2 mol/L acetate buffer (pH 4) and 200 ML of flavone internal standard (60 Mg/L in 96% ethanol) and filtered through a preconditioned C18 reversedphase solid-phase extraction (SPE) column (PGC Scientific, Gaithersburg, MD). We then washed the column with 2 mL of acetate buffer and eluted the analytes with 100% methanol. The eluate was dried with the Speed-Vac at room temperature, redissolved in 1.0 mL of 0.2 mol/L phosphate buffer (pH 7.0), mixed thoroughly with 50 ML of 13-glucuronidase [31] and 50 ML of arylsulfatase, and incubated for 1 h at 37 #{176}C. Subsequently, the enzymes of the hydrolyzed samples were inactivated by addition of 0.9 mL of 100% methanol. Mg/L in 96% ethanol) with 0.9 mL of buffer and 0.9 mL of methanol in the same batch to calculate recovery of the internal standard.
Trimethylsilylation.
Dry milk extracts or crystalline authentic standards were dissolved in 0.1 mL of 20 g/L N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA, Sigma) in imidazole and incubated for 15 mm at 60 #{176}C before GC-MS analysis.
Chromatography. All HPLC analyses were carried out on a 150 X 3.9 mm (i. I) were improved from our previous report [27] by including methanol and dichloromethane as additional organic modifiers in the mobile phase and by using a less-steep linear gradient. Better selectivity was achieved with the present system because it provided baseline separation of the soy isoflavones daidzein, glycitein, and genistein and of their acetyl and malonyl esters present in soy foods (not shown). In addition, the mammalian isoflavone metabolites equol and O-desmethylangolensin ( Fig. 2) as well as other dietary phytoestrogens such as formononetin, biochanin-A, and coumestrol (Fig. 2E) were selectively separated.
However, the present system led to laterretention times and thereby, to lower peak heights. Consequently, we calculated the detection limits for the analytes (Table 1 ) by using peak heights and found these to be slightly greater than those in the HPLC system used in our earlier report [27] . However, detection limits of analytes isolated from human milk and urine were 10-fold lower than those given in Table 1 (D) . Trace E shows the chromatogram of authentic standards, including coumestrol (peak with no number assigned). Flavone. used as internal standard. elutes after 31 mm (not shown). Analyte amounts in traces A (= C), B (= D), and E are, respectively: daidzein 3.7, 17.7, and 15.6 pmol; genistein 5.4, 7.9, and 11.7 pmol; equol 0 (below detection limit). 45.7, and 5.4 pmol; O.desmethylangolensin 0 (below detection limit), 12.1, and 57.7 pmol.
the detection limits by more than fivefold relative to those obtained by monitoring absorbance at the absorbance maximum for each analyte (Table 1) .
Although retention times were altered,the peak areas obtained by monitoring at the respective absorbance maxima of the analytes remained unchanged. Therefore, the present I-IPLC system showed sensitivity equal to that of the previously applied system [27] , as evidenced by the nearly identical slopes for the calibration curves. Sensitivity was further improved by using electrochemical detection instead of monitoring ultraviolet absorbance (Table i) Extractedfrom human urine.Because isoflavonoids occur in human urine mainly as sulfates and glucuronides [22, 33] , hydrolysis is recommended before HPLC analysis so that a less-complex chromatogram is obtained [27] . The sequence of enzymatic hydrolysis and SPE did not change the final results, which suggests a lack of enzyme inhibitors in urine. Also, phase separation with ethyl acetate gave similar yields relative to SPE. However, performing SPE first was found to be the fastest and most convenient method and therefore, was utilized in this study, as previously described [27] . Hydrolysis with a glucuronidase/sulfatase mixture prepared from H. pomatia showed interfering peaks with isoflavone signals in the HPLC chromatogram of human milk extracts; therefore, we used in all assays glucuronidase from E. co/i, which lacked these interfering compounds.
Extracted from human milk.Milk presents a unique challenge for isoflavone extraction because of the high content of proteins that easily form gel aggregates, leading to low recovery of analytes. Therefore, proteins have been removed from milk by precipitation [34, 35] (Table 2) , and glucosidic conjugates were not coextracted (data not shown). Therefore, hydrolysis of isoflavone conjugates was required before extraction so as to include these conjugates in the assay. The lack of detectable isoflavone concentrations after extraction without hydrolysis suggested that all isoflavones in human milk are present as conjugates.
Precision studies and analytical recoveries of analytes added to milk samples (Table 2) were found to be within accepted limits for phytoestrogen analyses [22-24/ and so confirmed the validity of the proposed procedure. 
Analytes
( Fig. 1) were routinely identified by retention times in various HPLC systems and by ultraviolet absorption patterns obtained by diode-array detection (Fig. 3) in comparison with authentic standards and with reported absorbance data [42, 43] . In addition, we used fluorometric [27, 41] and coulometric [44] detection to confirm the presence of these agents in human milk. Trimethylsilylation of representative milk extracts followed by GC-MS analysis in SIM mode again indicated the presence of daidzein and genistein in human milk because the GC retention times and the mass fragmentation patterns were identical to those of authentic standards (Fig. 4 and 5) . These GC-MS values were also in excellent agreement with those reported previously [26] . None of the other soy isoflavones or metabolites shown in Fig. 1 was detected in human milk extracts with this GC-MS/SIM method, from which we deduce their absence in human milk after soy consumption. 
Mas,!thgs
Clinical Cheinistiy 42, No. 6, 1996 Soybean challenge led to a fast and dose-dependent response [23, 27] . In contrast, analysis of human milk showed that only daidzein and genistein conjugates were above the HPLC detection limit, even after challenge with 25 g of roasted soybeans (data not shown). The exclusive occurrence of the major soy isoflavones in milk is not surprising; glycitein exposure through soy challenge is minor due to its low concentrations in soybeans [23, 45] . Preferential excretion of the metabolites over the parent isoflavones is suggested by the isoflavone:metabolite ratio, which is seen to be much higher in plasma than in urine or feces [24, 26] . Because milk is produced by secretory processes of blood [46] ,the low plasma concentrations of isoflavonoid metabolites in human blood might explain their absence in milk. (Fig. 6) . Maximum milk concentrations were reached 10-14 h after soy intake, and baseline was reached 2-4 days later, depending on the dose. The isoflavone patterns in milk followed those in urine except with a slight delay (Fig. 6 ). This is in good agreement with many other polar micronutrients or drugs, which show a faster urinary excretion than secretion into milk [46] . Most importantly, however, the Caucasian woman showed higher concentrations of genistein conjugates than those of daidzein conjugates in plasma and, because of secretory processes, also in milk. This is in contrast to higher daidzein than genistein concentrations observed in breast milk of a Chinese woman (see below), a pattern generally reported from plasma [24] , urine [22, 23, 27, 28] , and feces [26] , which suggests large interindividual variation. Milk concentrations of daidzein and genistein conjugates increased rapidly aftersoy consumption; this was followed by their rapid decrease and, most interestingly, by a subsequent increase before reaching baseline values (Fig. 6 ). This biphasic elimination pattern has already been observed in animal plasma after treatment with the flavane hydroxyfarrerol [47] or the flavone baicalin [39] and, more importantly, in human plasma [33] and urine [27] aftersoy intervention.
This biphasic phenomenon has been suggested to result from enterohepatic circulation [33] ,a process known to occur with flavonoids [48] . Enterohepatic circulation might also, therefore, explain the biphasic pattern observed in human milk.
Isoflavone concentrations in three milk and urine samples from a Chinese woman eating her usual diet (including tofu soup once a day for dinner) were analyzed by the proposed procedure.
The concentrations of daidzein and genistein in her milk (80-110 and 30-50 nmol/L, respectively) were similar to those observed in the Caucasian woman's milk after challenge with roasted soybeans. This is in good agreement considering the similar total isoflavone exposure from these two food items [17] . However, urinary excretion of these compounds was less by the Chinese woman (80-150 nmollh daidzein and 8-33 nmollh genistein) than by the Caucasian woman during soybean intervention. This difference may reflect interindividual variation in excretion [23, 27] decrease in cancer incidence and severityboth of which are significantly reduced when newborn animals are treated with only three single doses of genistein [13] .The data presented here suggest a cancer-preventive effect of breast-feeding to the offspring when mothers consume soy foods, in that such infants would be exposed to the known anticancer agent genistein and also daidzein. This effect, which would take place at a very early and most critical developmental period, might protect the individual throughout life. Also, our findings may provide the basis for an alternative explanation for the lower cancer rates observed in Asian populations with high consumption of soya. The lower cancer rates in these populations might not be the result of isoflavone exposure by soy consumption in adulthood or childhood [52] but rather of isoflavone exposure shortly after birth, in a critical period of life, through mother's milk containing these agents.
Conceivably, the isoflavone conjugates obtained from mother's milk are more bioavailable to the newborn child than are the conjugates from soy foods. Young infants might not be able to absorb isoflavones from soya because their gut flora are incompletely developed, preventing hydrolysis of the acylated and nonacylated isoflavone glucosides present in soy foods. Biotransformation and bioavailability studies of soy isoflavones in infants are required to further explore the cancer-preventive effects of these compounds in humans.
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